| dc.description.abstract | It’s increasingly recognized that SARS-CoV-2 can produce long-term chronic complications after recovering from the acute effects of the infection. But little is known about the prevalence, risks, or whether it’s possible to predict a long-term course of the disease in the early stages, the resulting quality of life disorder. In this study, the effects of chronic Covid-19 syndromes (CCS) on type, prevalence, quality of life after recovery in Covid-19 patients were investigated. Four weeks after the quarantine period of the patients was completed, a cross-sectional study was conducted with a questionnaire on people reached via Google forms to determine the symptoms of long-Covid. 1044 people over the age of 18, who aren’t pregnant, and who have had Covid-19 were included in the analysis. It was determined that 65.6% (n=685) of the participants continued to have symptoms after the PCR test was negative/after they recovered. It was concluded that myalgia, fatigue, joint pain, anosmia was observed in 76.4% (n=797) of the individuals participating in our study. It has been observed that people who have had Covid-19 commonly show additional or ongoing symptoms and associated impairment of quality of life in the short term. It was determined that individuals who initially had a symptom of shortness of breath or lung involvement were more likely to develop long-term symptoms. More importantly, our study revealed that the overall disease level is an important variable that should be considered when assessing the statistical significance of symptoms associated with Covid-19. © IJCESEN. | en_US |
| dc.department-temp | Say A., Amasya University, Sabuncuoğlu Şerefeddin Vocational School of Health Services, Amasya, Türkiye; Çakir D., Tokat Gaziosmanpasa University, Faculty of Health Sciences, Midwifery Department, Tokat, Türkiye; Avramescu T., University of Craiova, Craiova, Romania; Üstün G., Amasya University, Faculty of Health Sciences, Department of Psychiatric Nursing, Amasya, Türkiye; Neagoe D., University of Medicine and Pharmacy of Craiova, Department of Internal Medicine, Craiova, Romania; Kahveci M., Amasya University, Faculty of Medicine, Department of Anesthesia and Reanimation, Amasya, Türkiye; Zhelev Y., Burgas Free University, Burgas, Bulgaria; Monova-Zheleva M., Burgas Free University, Burgas, Bulgaria; Komorek J., The Academy of Business and Health Sciences, Łódź, Poland | en_US |
